Vitamin E Nail Oils: Reading the 2020 Onychomycosis Study
A 2020 open study tested a nail oil combining vitamin E and essential oils in mild-to-moderate toenail fungus — the closest published analog to Kerassentials' formula style. This article reads the study the way it should be read: what it did, what it found, what it cannot say, and why it is not a Kerassentials trial.
The study at a glance
Alessandrini et al. (Skin Appendage Disorders, 2020) ran an open, uncontrolled study of a nail oil composed of vitamin E plus essential oils in adults with mild-to-moderate distal subungual onychomycosis. Participants applied the oil per protocol over months; outcomes were assessed clinically and mycologically, and the authors reported improvement and mycological cure in a substantial share of participants, with good tolerability.
What makes it interesting
Three things. First, it is a human, nail-specific, essential-oil-plus-vitamin-E study — precisely the formula architecture Kerassentials uses, which makes it the most relevant single paper in the product's evidence orbit. Second, it targeted mild-to-moderate distal disease — the segment where topicals are biologically plausible. Third, tolerability was good, supporting the gentleness case for oil blends as a category.
What limits it
The design words that must travel with every citation: open (no blinding), uncontrolled (no comparison arm), small. Without a control group, regression-to-mean, grooming effects and natural variance all compete as explanations; without blinding, assessment bias joins them. Good journals publish such studies as signals, not verdicts — and the authors' own framing is appropriately cautious.
Why it is not a Kerassentials trial
Three clean reasons, worth memorizing because marketing will blur them: the study tested a different formula (its own vitamin E/essential-oil composition and concentrations), under its own protocol, in its own sample. A similar blend's encouraging result raises the category's plausibility; it does not constitute evidence that any named commercial blend works. Our how it works page applies the same rule to every citation, and the editorial policy makes the rule binding.
What a careful buyer may still take from it
Legitimately: (1) essential-oil nail oils have produced encouraging human signals in mild disease, so the category is not evidence-empty; (2) tolerability in such studies supports the gentle-profile positioning; (3) the studied population — mild-to-moderate distal cases, consistent application, months-long timelines — describes exactly who should consider (not expect) results from oil blends, and the patience required. It is a map of realistic expectations, which is valuable even when it is not proof.
The vitamin E chemistry behind the anchor
Tocopheryl acetate, the blend's vitamin E ester, is a stable antioxidant and skin-conditioning agent; in nail oils it plays both skin-protective roles and formulation chemistry (protecting the oils themselves from oxidation). Its presence is what makes the 2020 study architecturally relevant — and what our ingredients hub calls the formula's quiet anchor.
Verdict on the study
A well-placed, honestly-limited signal: encouraging for the category, silent about the brand. Cite it with its design words attached and it strengthens a buyer's understanding; strip them off and it becomes the very marketing blur this site exists to correct.
References
- Alessandrini A, Starace M, Bruni F, et al. An open study to evaluate effectiveness and tolerability of a nail oil composed of vitamin E and essential oils in mild to moderate distal subungual onychomycosis. Skin Appendage Disord. 2020;6(1):14-8.
- NIH / NCBI vitamin E (tocopherols, tocopheryl acetate) skin and nail literature.
- Kerassentials official product page (vendor). Accessed September 2026.